Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,672
Total Claims
$979K
Drug Cost
810
Beneficiaries
$1,208
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+172%
Opioid rate vs peers
54.9% vs 20.2% avg
+165%
Cost per patient vs peers
$1,208 vs $455 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
54.9%
Opioid Rate
5,307
Opioid Claims
$398K
Opioid Cost
21.4%
Long-Acting Rate
This provider's opioid prescribing rate of 54.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 8,857 claims · $292K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Denosumab | 88 | $146K |
| Oxycodone Myristate | 165 | $117K |
| Abaloparatide | 39 | $107K |
| Teriparatide | 20 | $81K |
| Hydrocodone/Acetaminophen | 1,527 | $39K |
| Oxycodone Hcl/Acetaminophen | 1,209 | $38K |
| Oxycodone Hcl | 75 | $33K |
| Tapentadol Hcl | 22 | $32K |
| Buprenorphine Hcl | 39 | $32K |
| Fentanyl | 200 | $18K |
| Vortioxetine Hydrobromide | 35 | $17K |
| Tapentadol Hcl | 17 | $17K |
| Naloxegol Oxalate | 31 | $14K |
| Oxycodone Hcl | 595 | $11K |
| Linaclotide | 18 | $11K |
Prescribing Profile
70
Unique Drugs
21.0
Anomaly Score
Patient Profile
70
Avg Age
64%
Female
1.46
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About